Stocksigma LogoStocksigma Logo

Gennex Laboratories Schedules Board Meeting on 14th Nov'26 to Consider Q2 Results

Gennex Laboratories Limited has scheduled a Board of Directors meeting on 14th Nov'26 to consider and adopt the unaudited standalone and consolidated

Gennex Laboratories Schedules Board Meeting on 14th Nov'26 to Consider Q2 Results

Gennex Laboratories Ltd 路 Intimation 路 14 Nov 2026, 5:30 am

Gennex Laboratories Schedules Board Meeting on 14th Nov'26 to Consider Q2 Results Gennex Laboratories Limited has scheduled a Board of Directors meeting on 14th Nov'26 to consider and adopt the unaudited standalone and consolidated financial results, along with the Statutory Auditor's Limited Review Reports, for the quarter and half-year ended 30th Sep'26. The company's trading window for dealing in securities, which closed on 1st Oct'26, will reopen 48 hours after the declaration of the financial results for all designated and connected persons.

Original exchange filing (PDF)

More announcements from Gennex Laboratories Ltd

All Gennex Laboratories Ltd announcements